Figure 9. Alterations in CREBp-1, AMPK protein (a), metabolic intermediates beta-hydroxybutyrate (b) and acetoacetate (c) levels in vehicle control, NLCs-KAA, NLCs-PUNI-KAA and PUNI and orlistat treated maturing adipocyte after 14 days. Each of the values are means ± SD (n = 6). Sign...